Inventor · disambiguated record
Saswati Chatterjee
Also filed as: CHATTERJEE SASWATI
24 granted patents·6 pending applications·1,063 citations·filing 1993–2024
96Inventor score
Top patents by PatentIndex Score
30 records- 0198US9803218B2Recombinant adeno-associated vectors for targeted treatmentHOPE CITY·Filed 2016·Granted Oct 31, 2017·37 cites·46 claims
- 0298US9783825B2Recombinant adeno-associated vectors for targeted treatmentHOPE CITY·Filed 2017·Granted Oct 10, 2017·35 cites·39 claims
- 0398US9777291B2Recombinant adeno-associated vectors for targeted treatmentHOPE CITY·Filed 2017·Granted Oct 3, 2017·35 cites·33 claims
- 0497US9890396B2Adeno-associated virus vector variants for high efficiency genome editing and methods thereofHOPE CITY·Filed 2016·Granted Feb 13, 2018·31 cites·85 claims
- 0597US8927514B2Recombinant adeno-associated vectors for targeted treatmentHOPE CITY·Filed 2012·Granted Jan 6, 2015·227 cites·15 claims
- 0696US9839696B2Recombinant adeno-associated vectors for targeted treatmentHOPE CITY·Filed 2017·Granted Dec 12, 2017·11 cites·24 claims
- 0796US9834789B2Recombinant adeno-associated vectors for targeted treatmentHOPE CITY·Filed 2017·Granted Dec 5, 2017·12 cites·14 claims
- 0896US9623120B2Recombinant adeno-associated vectors for targeted treatmentHOPE CITY·Filed 2014·Granted Apr 18, 2017·62 cites·18 claims
- 0994US8628966B2CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transferCHATTERJEE SASWATI·Filed 2011·Granted Jan 14, 2014·144 cites·13 claims
- 1092US5474935AAdeno-associated virus (AAV)-based eucaryotic vectorsUS ARMY·Filed 1993·Granted Dec 12, 1995·440 cites·11 claims
- 1190US2025154534A1Adeno-associated virus vector variants for high efficiency genome editing and methods thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 1286US11434504B2Adeno-associated virus vector variants for high efficiency genome editing and methods thereofHOPE CITY·Filed 2020·Granted Sep 6, 2022·1 cites·24 claims
- 1385US10596273B2Recombinant adeno-associated vectors for targeted treatmentHOPE CITY·Filed 2017·Granted Mar 24, 2020·1 cites·66 claims
- 1485US2024207447A1Recombinant Adeno-Associated Vectors For Targeted TreatmentHOPE CITY·Filed 2023·Application pending·0 cites
- 1583US11965174B2Adeno-associated virus vector variants for high efficiency genome editing and methods thereofHOPE CITY·Filed 2022·Granted Apr 23, 2024·0 cites·24 claims
- 1683US8926958B2Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein A-I and apolipoprotein A-I milanoSHAH PREDIMAN K·Filed 2005·Granted Jan 6, 2015·9 cites·11 claims
- 1782US2024279581A1System, device and method for production of bioproduct including high density cell respirator (hdcr) for intensified production of adeno-associated viruses (aav) and cell-based productionHOPE CITY·Filed 2024·Application pending·0 cites
- 1878US10443075B2Adeno-associated virus vector variants for high efficiency genome editing and methods thereofHOPE CITY·Filed 2018·Granted Oct 15, 2019·1 cites·85 claims
- 1973US11981885B2System, device and method for production of bioproduct including high density cell respirator (HDCR) for intensified production of adeno-associated viruses (AAV) and cell-based productionHOPE CITY·Filed 2020·Granted May 14, 2024·0 cites·21 claims
- 2073US11891619B2Adeno-associated virus compositions for restoring F8 gene function and methods of use thereofHOPE CITY·Filed 2022·Granted Feb 6, 2024·0 cites·21 claims
- 2173US11833226B2Recombinant adeno-associated vectors for targeted treatmentHOPE CITY·Filed 2020·Granted Dec 5, 2023·0 cites·27 claims
- 2273US7122348B2AAV2 Rep protein fusionsHOPE CITY·Filed 2003·Granted Oct 17, 2006·5 cites·15 claims
- 2371US9783805B2Replication capable rAAV vectors encoding inhibitory siRNA and methods of their useHOPE CITY·Filed 2014·Granted Oct 10, 2017·1 cites·17 claims
- 2463US11306329B2Adeno-associated virus compositions for restoring F8 gene function and methods of use thereofHOPE CITY·Filed 2019·Granted Apr 19, 2022·0 cites·18 claims
- 2561US2017198265A1Adeno-associated virus vector variants for high efficiency genome editing and methods thereofHOPE CITY·Filed 2017·Application pending·0 cites
- 2658US2025101465A1Adeno-associated virus compositions and methods of use thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 2757US10370662B2Replication capable rAAV vectors encoding inhibitory siRNA and methods of their useHOPE CITY·Filed 2017·Granted Aug 6, 2019·0 cites·13 claims
- 2856US2025312486A1Compositions for restoring mecp2 gene function and methods of use thereofHOPE CITY·Filed 2023·Application pending·0 cites
- 2950US6919209B1Method of genetically modifying very primitive quiescent human hematopoietic stem cellsHOPE CITY·Filed 1999·Granted Jul 19, 2005·11 cites·11 claims
- 3047US12201657B2Adeno-associated virus compositions for restoring HBB gene function and methods of use thereofHOPE CITY·Filed 2018·Granted Jan 21, 2025·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Saswati Chatterjee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →